Cas No.: | 1510829-06-7 |
Chemical Name: | (3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxo[1,3'-bipiperidine]-4'-carboxamide |
Synonyms: | SNS 062;SNS062;SNS-062 |
Formula: | C22H24ClF4N7O2 |
M.Wt: | 529.925 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Vecabrutinib (SNS-062) is a potent, reversible, non-covalent BTK inhibitor with IC50 of 2.9 and 4.4 nM for WT BTK and C481S BTK, respectively; Binds to Tec kinase family members BTK (Kd=0.3 nM) and ITK (Kd=2.2 nM), but not bind EGFR, active in vitro in cells with the C481S mutation; Inhibits pBTK in human whole blood with IC50 of 50 nM, demonstrates favorable pharmacokinetic properties, shows potential for overcoming the ibrutinib resistance due to C481S mutantion in BTK. Blood Cancer Phase 2 Clinical |